Abstract
Background
This study was aimed to evaluate the antibiotic resistance, biofilm formation, and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa (CRPA) strains isolated from four types of nosocomial infections (NIs) including urinary tract infection (UTI), ventilator-associated pneumonia (VAP), surgical site infection (SSI), and bloodstream infection (BSI).
Methods and results
In total, 115 isolates of NIs-causing P. aeruginosa were collected from NIs. Antibiotic susceptibility testing (AST) was performed using disk diffusion method and minimum inhibitory concentrations. Biofilm formation was tested on 96-well polystyrene microtiter plates (MTP). CRPA isolates were genotyped using multiple-locus variable number of tandem repeat analysis (MLVA). The most resistance and susceptibility rates were observed to amikacin (70.6%) and colistin (96.1%), respectively. Colistin and meropenem were the most active antimicrobial agents in VAP, SSI, and BSI. While, colistin and cefepime were the most active in UTIs. In total, 52.2% (n = 60/115) of P. aeruginosa isolates were carbapenem resistant, of which 95.0%, 55.0%, and 5.0% were multidrug-resistant, extensively drug-resistant, and pandrug-resistant, respectively. There was a significant association between resistance to carbapenem and resistance to other antibiotics except for piperacillin/tazobactam. The biofilm production of CRPA isolates was 95.0%, of which 23.3% were strong biofilm producers. Based on MLVA, there were 34 different types of CRPA isolates classified into three main clusters and 5 sub clusters.
Conclusion
The association of CRPA with other antibiotic resistance, the high rates of biofilm production, and the high genetic diversity of the isolates may be a warning of the need for a careful surveillance program.


Similar content being viewed by others
Data availability
All analyzed data within this study can be obtained from the corresponding author on request.
Code availability
Not applicable.
References
Nouri F, Karami P, Zarei O, Kosari F, Alikhani MY, Zandkarimi E et al (2020) Prevalence of common nosocomial infections and evaluation of antibiotic resistance patterns in patients with secondary infections in Hamadan. Iran Infect Drug Resist 13:2365
Labovská S (2021) Pseudomonas aeruginosa as a cause of nosocomial infections. Pseudomonas aeruginosa-biofilm formation, infections and treatments IntechOpen. https://doi.org/10.5772/intechopen.9590
Mohammadi M, Vaisi Raiegan A, Jalali R, Ghobadi A, Salari N, Barati H (2019) The prevalence of nosocomial infections in Iranian hospitals. J Babol Uni Med Sci 21:39–45
Izadi N, Eshrati B, Etemad K, Mehrabi Y, Hashemi-Nazari S-S (2020) Rate of the incidence of hospital-acquired infections in Iran based on the data of the national nosocomial infections surveillance. New Microb New Infect 38:100768
Bogiel T, Prażyńska M, Kwiecińska-Piróg J, Mikucka A, Gospodarek-Komkowska E (2021) Carbapenem-resistant Pseudomonas aeruginosa strains-distribution of the essential enzymatic virulence factors genes. Antibiotics 10:8
Hu Y-Y, Cao J-M, Yang Q, Chen S, Lv H-Y, Zhou H-W et al (2019) Risk factors for carbapenem-resistant Pseudomonas aeruginosa, Zhejiang Province. China Emerg Infect Dis 25:1861
Xu Y, Niu H, Hu T, Zhang L, Su S, He H et al (2020) High expression of Metallo-β-lactamase contributed to the resistance to carbapenem in clinical isolates of Pseudomonas aeruginosa from Baotou. China Infect Drug Resist 13:35
Kunwar A, Shrestha P, Shrestha S, Thapa S, Shrestha S, Amatya NM (2021) Detection of biofilm formation among Pseudomonas aeruginosa isolated from burn patients. Burns Open 5:125–129
Olivares E, Badel-Berchoux S, Provot C, Prévost G, Bernardi T, Jehl F (2020) Clinical impact of antibiotics for the treatment of Pseudomonas aeruginosa biofilm infections. Front Microbiol 10:2894
Patel C, Shah M, Singh S, Modi C, Shah P (2021) Biofilm production and antimicrobial resistance in catheter associated urinary tract infection (CAUTI) pathogens isolated from ICU patients. Eur J Mol Clin Med 8:3143–3152
El-Mahdy R, El-Kannishy G (2019) Virulence factors of carbapenem-resistant Pseudomonas aeruginosa in hospital-acquired infections in Mansoura. Egypt Infect Drug Resist 12:3455
Sawa T, Momiyama K, Mihara T, Kainuma A, Kinoshita M, Moriyama K (2020) Molecular epidemiology of clinically high-risk Pseudomonas aeruginosa strains: practical overview. Microbiol Immunol 64:331–344
Shokoohizadeh L, Alizade H, Namordizadeh V, Karmostaji A (2020) Tandem repeat analysis for typing of Pseudomonas aeruginosa carrying resistance genes in southern Iran. Rev in Med Microbiol 31:92–98
Santos MDV, Barros MPS, Silveira-Filho VdM, Mendes-Marques CL, Lima AVA, Silva MVd et al (2021) Genetic and biochemical diversity of clinical Acinetobacter baumannii and Pseudomonas aeruginosa isolates in a public hospital in Brazil. Microb Drug Resist 27:509–517
Control CfD, Prevention (2020) CDC/NHSN Surveillance definitions for specific types of infections.
Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A (2020) Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes 13:1–6
Rouhi S, Ramazanzadeh R, Nouri B (2019) Genotyping, pandrug resistance, extensively drug-resistant, and multi drug-resistance detection of Pseudomonas aeruginosa isolated from patients in the west of Iran. Cres J Med Biol Sci 6:170–177
Clinical and Laboratory Standards Institute (2020) Performance standards for antimicrobial susceptibility testing, 30 ed. CLSI supplement M100-S30. Clinical and Laboratory Standards Institute, Wayne, PA
Magiorakos A-P, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281
Davarzani F, Saidi N, Besharati S, Saderi H, Rasooli I, Owlia P (2021) Evaluation of antibiotic resistance pattern, alginate and biofilm production in clinical isolates of Pseudomonas aeruginosa. Iran J Public Health 50:341
Bahador N, Shoja S, Faridi F, Dozandeh-Mobarrez B, Qeshmi FI, Javadpour S et al (2019) Molecular detection of virulence factors and biofilm formation in Pseudomonas aeruginosa obtained from different clinical specimens in Bandar Abbas. Iran J Microbiol 11:25
Vu-Thien H, Corbineau G, Hormigos K, Fauroux B, Corvol H, Clément A et al (2007) Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. J Clin Microbiol 45:3175–3183
Angeletti S, Cella E, Prosperi M, Spoto S, Fogolari M, De Florio L et al (2018) Multi-drug resistant Pseudomonas aeruginosa nosocomial strains: Molecular epidemiology and evolution. Microb Pathog 123:233–241
Rodulfo H, Arcia A, Hernández A, Michelli E, Martinez DdV, Guzman M et al (2019) Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital. Rev Inst Med Trop Sao Paulo 61:e20
Oumeri MMQ, Yassin NA (2021) Molecular characterization of some carbapenem-resistance genes among Pseudomonas aeruginoza isolated from wound and burn infection in Duhok city, Iraq. J Duhok Uni 24:136–144
Gajdács M, Baráth Z, Kárpáti K, Szabó D, Usai D, Zanetti S et al (2021) No Correlation between biofilm formation, virulence factors and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics 10:1134
Vaez H, Moghim S, Nasr Esfahani B, Ghasemian Safaei H (2015) Clonal relatedness among imipenem-resistant Pseudomonas aeruginosa isolated from ICU-hospitalized patients. Crit Care Res Pract 2015:983207
Motbainor H, Bereded F, Mulu W (2020) Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis 20:1–11
Mekonnen H, Seid A, Molla G, Gebrecherkos T (2021) Antimicrobial resistance profiles and associated factors of acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia: a cross sectional study. PLoS ONE 16:e0257272
Lila G, Mulliqi G, Raka L, Kurti A, Bajrami R, Azizi E (2018) Molecular epidemiology of Pseudomonas aeruginosa in University clinical center of Kosovo. Infect Drug Resist 11:2039
Rouhi S, Ramazanzadeh R (2018) Prevalence of blaOxacillinase-23 and blaOxacillinase-24/40 carbapenemase genes in Pseudomonas aeruginosa isolated from patients with nosocomial and non-nosocomial infections in West of Iran. Iran J Pathol 13:348–356
Kresken M, Körber-Irrgang B, Korte-Berwanger M, Pfennigwerth N, Gatermann SG, Seifert H et al (2020) Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany. Int J Antimicrob Agents 55:105959
Hemmati H, Hasannejad-Bibalan M, Khoshdoz S, Khoshdoz P, Kalurazi TY, Ebrahim-Saraie HS et al (2020) Two years study of prevalence and antibiotic resistance pattern of Gram-negative bacteria isolated from surgical site infections in the North of Iran. BMC Res Notes 13:1–6
Djordjevic ZM, Folic MM, Jankovic SM (2017) Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. J Infect Public Health 10:740–744
Takesue Y, Watanabe A, Kusachi S, Matsumoto T, Iwamoto A, Totsuka K et al (2012) Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. J Infect Chemother 18:816–826
Voor in ‘t holt AF, Severin JA, Lesaffre EM, Vos MC (2014) A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 58:2626–2637
Rasool AA, Almohana AM, Alsehlawi ZS, Ali IA, Al-faham MAAA, Al-sherees HAA (2021) Molecular detection of carbapenems resistance genes in Pseudomonas aeruginosa isolated from different hospital in najaf, Iraq. Int J Inform Res Rev 8:7242–7247
Cho HH, Kwon KC, Kim S, Park Y, Koo SH (2018) Association between biofilm formation and antimicrobial resistance in carbapenem-resistant Pseudomonas aeruginosa. Ann Clin Lab Sci 48:363–368
Cepas V, López Y, Muñoz E, Rolo D, Ardanuy C, Martí S et al (2019) Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microb Drug Resist 25:72–79
Uppe A, Gupta D, Sawant S, Nair G (2019) Incidence of biofilm formation in ET tube and correlation with occurrence of VAP in a tertiary care ICU. Am J Infect Dis 7:65–72
Baidya S, Sharma S, Mishra SK, Kattel HP, Parajuli K, Sherchand JB (2021) Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital: an armor for refuge. BioMed Res Int 2021:8817700
Hosseini Doust SR, Mahmoudi Jouibari M (2018) Corelation between antibiotic resistans and biofilm formation power of Pseudomonas aeruginosa. J Pharm Health Sci 6:21–28
El-sayed H, Fahmy Y (2021) Correlation between biofilm formation and multidrug resistance in clinical isolates of Pseudomonas aeruginosa. Microb Infect Dis 2:541–549
Karami P, Khaledi A, Mashoof RY, Yaghoobi MH, Karami M, Dastan D et al (2020) The correlation between biofilm formation capability and antibiotic resistance pattern in Pseudomonas aeruginosa. Gene Rep 18:100561
Karballaei Mirzahosseini H, Hadadi-Fishani M, Morshedi K, Khaledi A (2020) Meta-analysis of biofilm formation, antibiotic resistance pattern, and biofilm-related genes in Pseudomonas aeruginosa isolated from clinical samples. Microb Drug Resist 26:815–824
Lashgarian H, Marzban A, Estaji M, Gholami M, Masoumi asl H, Raheb J, (2018) Multiple locus variable number tandem repeat analysis (MLVA) for typing Pseudomonas aeruginosa isolated from urine samples of different patients. J Babol Uni Med Sci 20:56–56
Jarych D, Augustynowicz-Kopec E, Iwanska A, Parniewski P, Majchrzak M (2021) Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Sci Rep 11:15460
Lalancette C, Charron D, Laferrière C, Dolcé P, Déziel E, Prévost M et al (2017) Hospital drains as reservoirs of Pseudomonas aeruginosa: multiple-locus variable-number of tandem repeats analysis genotypes recovered from faucets, sink surfaces and patients. Pathogens 6:36
Johansson E, Welinder-Olsson C, Gilljam M, Pourcel C, Lindblad A (2015) Genotyping of Pseudomonas aeruginosa reveals high diversity, stability over time and good outcome of eradication. J Cyst Fibros 14:353–360
Acknowledgements
This study was a part of the Ph.D. thesis of Reza Heidari. The cooperation of the Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences is acknowledged. Our appreciation also goes to the Vice Chancellor for Research affairs, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, and Tropical and Infectious Diseases Research Center of the University for their financial (Grant No. OG-9940) and executive support.
Funding
This work was supported by the Vice Chancellor for Research affairs, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, and Tropical and Infectious Diseases Research Center of the University (Grant No. OG-9940).
Author information
Authors and Affiliations
Contributions
RH and AFS: conceptualization, methodology, writing- original draft preparation, writing-reviewing and editing, formal analysis. MH: methodology, data curation, formal analysis, writing- original draft preparation. ZF: conceptualization, data curation, formal analysis, writing-reviewing and editing. SS: conceptualization, supervision, writing-reviewing and editing. Writing- original draft preparation. MS: writing-reviewing and editing, formal analysis. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest.
Ethical approval
Ethical approval was obtained from the Ethics Committee of the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (IR.AJUMS.REC.1399.530). Written informed consent was obtained from all patients.
Consent to participate
All patients provided written informed consent.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Heidari, R., Farajzadeh Sheikh, A., Hashemzadeh, M. et al. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran. Mol Biol Rep 49, 3811–3822 (2022). https://doi.org/10.1007/s11033-022-07225-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-07225-3